AZBIL TELSTAR OPENS ITS NEW SUBSIDIARY IN BANGLADESH AND REINFORCES ITS LEADING POSITION IN THE ASIA-PACIFIC REGION
- Telstar has enhanced its global activities in engineering and construction for local and multinational pharmaceutical companies
- The ability to offer comprehensive high-technology solutions in engineering, construction and process equipment for the life sciences market has led to Telstar being acknowledged as one of the 10 major suppliers to the pharmaceutical industry
The Azbil Telstar subsidiary in Dhaka, Bangladesh, was formally inaugurated on 2nd of April, 2014. The opening of Telstar's new center, which is specifically focused on reinforcing a professional and specialized service in the Asia-Pacific region's pharmaceutical market, is in response to a requirement to promote growth in a region where the company has been active over the past 10 years. At the same time, Azbil Telstar is reinforcing its global activities in engineering, construction and manufacturing processes for development of turnkey plants and installations for local and multinational pharmaceutical companies with high growth potential.
Azbil Telstar is focused on providing global high-tech solutions in design, engineering, construction and manufacturing processes with automation technologies for the international life science markets, such as biopharmaceutical, life science research, personalized medicine, regenerative medicine and functional foods. Through the opening of the new center, the Telstar brand is now represented in this region by three specialized production plants and engineering centers in China, Bangladesh and India.
The pharma industry, a flagship sector in Bangladesh
At the inauguration ceremony of the new center in Bangladesh, which was attended by 120 people, Azbil Telstar received the explicit support of the political authorities, institutional representatives and business leaders. The Minister of Health and Family Welfare of Bangladesh, Mohammed Nasim, acted as Chief Guest at the ceremony and extended congratulations for the interest and trust of Azbil Telstar in the Bangladeshi pharmaceutical industry, the flagship sector in Bangladesh, and for devising their own technological innovations to further develop the industry, with the help of a local team, and for the decision of the company to invest in services that will support advanced areas such as life science research and regenerative medicine. In addition, the Bangladesh Association of Pharmaceutical Industries (BAPI)'s President, Salman Rahman, emphasized the relevant role of the pharmaceutical sector in the successful accomplishment of the millennium development Goals in the Health Sector of Bangladesh and highlighted that Azbil Telstar is a such dynamic company that is involved in R+D and innovating newer technologies with the need of a constantly evolving pharmaceutical industry worldwide and we hope the company will further furnish to a great extent our beloved sector.
Finally, Azbil Telstar's Chairman, Ton Capella, who expressed the commitment of the company to contribute to the development of the Bangladeshi society, said that we are convinced that the ability and know-how of our company will provide high added-value to Bangladesh, one of the fastest growing regions in the world. Ton Capella also mentioned Square Pharmaceuticals and in particular its founder Samson H. Chowdhury and expressed gratitude for the support received during the past 12 years. Square MD Tapan Chowdhury had words of praise for the existing good relationship between the two companies indicating that four production units have been successfully constructed for Square by Telstar: the Cephalosporin, Oral Solids Dose, Insulin and Large Volume Parenteral facilities.
Political and business support
The ceremony also benefitted from the presence of other dignitaries, including the Ambassadors of Japan and Spain in Bangladesh, Shiro Sadoshima and Luis Tejada, respectively, the Secretary General of BAPI, Abdul Muktadir, and the Director General of Drug Administration, Mohammed Jahangir Hossain Mollik, all of whom were received by Azbil Telstar's Chairman, Ton Capella; Saka Managing Director, S.A.Khan; General Manager of the Life Science Engineering Department at Azbil Corporation, Hideya Saito, and; Azbil Telstar Bangladesh Managing Director, Rafael Beaus.
Azbil Telstar operates in over a hundred countries and has 7 production plants, 7 technology centers and 13 consulting and engineering services centers all over the world. Acknowledged as one of the 10 major suppliers for the pharmaceutical industry, Telstar is the only international brand able to offer integrated process solutions for the biopharmaceutical industry with in-house sterilization, freeze drying, containment and clean air technologies. Azbil Telstar invests 3% of its turnover in R&D+i.
Telstar brand is part of Azbil, the leading Japanese group in building automation for the building market, advanced automation for the industry market and life automation systems for the life sciences and healthcare markets. The group develops its own regulation, control and automation technologies, equipment and systems for use in industry and in buildings. The Azbil group, which is listed on the Tokyo stock exchange, was founded in 1906 and currently has a workforce of 10,000 people worldwide.
For more information:
Phone: +34 93 736 16 00
E-mail: [email protected]